CAS: 2618-25-9; 2,4,6,2',4',6'-Hexaiodo-3,3'-(3-Oxa-Pentanedioyldiamino)-Di-Benzoic Acid

该化合物是一种属于氨基酸类别的化学化合物,其特点是存在碳酸和铁矿功能组,这些组有氨基酸衍生物的特性;该化合物一般是白色晶状固体,在水中可溶解,在标准条件下呈现相对稳定的结构;已知的有机芳烃酸有其在各个领域的潜在用途,包括制药和生物化学,可以用作浸泡物合成的构件或有机合成的试剂;其独特的结构允许它参与各种化学反应,使其成为研究和工业应用的宝贵化合物;此外,与许多氨基酸一样,它可能在生物过程发挥作用,尽管具体的生物功能和机制可能需要进一步调查;

结构式图片

MSDS等安全信息

    上下游产品

    3-氨基-2,4,6-三碘苯甲酸 3-Amino-2,4,6-Triiodobenzoic Acid 3119-15-1

    合成工艺路线路线简述

      📜2,2'-氧化二乙酰氯,3-氨基-2,4,6-三碘苯甲酸置于氯苯体系中,化学反应生成3,3'-[氧基二[(1-氧代-2,1-乙二基)亚氨基]]二[2,4,6-三碘-苯甲酸
      参考文献:Priewe Et Al.,Chemische Berichte,1954,Vol. 87,P. 651,652
      标题:Priewe Et Al.,Chemische Berichte,1954,Vol. 87,P. 651,652

      海关参考信息

      专利信息


      专利号:US-2022233673-A1
      优先权日:2019-06-04
      标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
      发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
      权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
      摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

      专利号:US-2011104052-A1
      优先权日:2007-12-03
      标 题 :Methods of synthesis and use of chemospheres
      发明人:BARNETT BRADLEY POWERS; GESCHWIND JEFFREY
      权利人:UNIV JOHNS HOPKINS
      摘要:The present invention provides, in general, compositions comprising a hydrogel and an agent, for example a therapeutic agent or an imaging agent, for locoregional delivery. In certain preferred embodiments of the invention, the hydrogel compositions are detectable by Magnetic Responance and CT Scan and are used for locoregional delivery of therapeutic agents, for example chemotherapeutic agents. The invention also features polymer matrix compositions comprising nanoparticles that can be loaded after polymerization with bioactive agents, for example a diagnostic agent or therapeutic agent.

      专利号:US-2016138027-A1
      优先权日:2013-03-14
      标 题:Treatment of diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mtorc1)
      发明人:GAN LIN; MEYER TOBIAS
      权利人:UNIV LELAND STANFORD JUNIOR
      摘要:Compositions and methods for treating diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mTORC1) are disclosed. The invention is based in part on the discovery that protein mediator of amino acid signaling to mTOR (MORTOR) is involved in amino acid-induced translocation of mTORC1 to lysosomes where MORTOR forms a signaling complex with mTORC1, Ragulator, and Rag GTPases, which controls protein synthesis. In particular, the invention relates to the use of antagonists of MORTOR for treating diseases and conditions associated with dysregulation of mTORC1. Downregulation of expression of MORTOR by RNA interference has been shown to reduce cell proliferation of cancerous cells and may be useful for treating cancer.

      专利号:US-2022233727-A1
      优先权日:2019-06-13
      标题:Surface enhanced raman scattering nanoparticles and their use in detecting and imaging oxidative stress
      发明人:THAKOR AVNESH S; RAZAVI MEHDI
      权利人:UNIV LELAND STANFORD JUNIOR
      摘要:Surface enhanced Raman scattering (SERS) nanoparticles and methods of using them for detecting reactive oxygen species are disclosed. In particular, methods of using SERS nanoparticles to detect and quantify reactive oxygen species Synthesis and monitor oxidative stress and disease-relevant changes in levels of reactive oxygen species are provided.

      专利号:US-2014315720-A1
      优先权日:2012-10-24
      标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
      发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
      权利人:CELANESE ACETATE LLC
      摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

      专利号:EP-2229147-A2
      优先权日:2007-12-03
      标 题 :Methods of synthesis and use of chemospheres

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Fleck C, Kabath P, Linstedt A, Linstedt U, Scharke U, Bräunlich H. Relation between renal and hepatic excretion of drugs. XIV. Elimination of ioglycamic acid after nephrectomy, bile duct ligation, and after treatment with hormones or xenobiotics in young and adult rats. Exp Pathol. 1991;43(1-2):75-87.

      合成参考文献


      参考文献:10.2165/00003088-199630030-00003
      摘要:Pichini S, Altieri I, Zuccaro P, Pacifici R. Drug monitoring in nonconventional biological fluids and matrices. Clin Pharmacokinet. 1996 Mar;30(3):211–28. doi: 10.2165/00003088-199630030-00003.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知